May 16th, 2022
From the desk of The Editor
Dear Reader,
HealthTechMovers.com has identified several healthtech stocks which are expected to go “Ex-Dividend” starting today, May 16th. Remember, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Lemaitre Vascular
Symbol: LMAT
Recent Price: $$43.29
Average Analyst Price Target: $50.00 (15.51%)
Market Cap: $$950.19M
Expected Ex-Dividend Date: May 16 2022
Expected Payment Date: Jun 02 2022
Expected Dividend & Yield: 1.08%
Recent Analyst Action: Michael Petusky, analyst at Barrington, reiterates coverage on Lemaitre Vascular (LMAT) in the Healthcare sector with a Buy rating and a price target of $ 50 (2 weeks ago).
Click for full story >>Recent Analyst Action: Douglas Lane, analyst at Lane Research, reiterates coverage on LifeVantage (LFVN) in the Healthcare sector with a Buy rating and a price target of $ 7 (1 week ago).
Click for full story >>Recent Analyst Action: Eric Coldwell, analyst at Robert W. Baird, reiterates coverage on Laboratory (LH) in the Healthcare sector with a Buy rating and a price target of $ 325 (4 days ago).
Click for full story >>Recent Analyst Action: Piyush Choudhary, analyst at HSBC, reiterates coverage on Sea (SE) in the Consumer Goods sector with a Buy rating and a price target of $ 145 (1 week ago).
Click for full story >>